1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 22
2.2 Major Growth Drivers 24
2.3 Market Restraints and Challenges 30
2.4 Emerging Opportunities and Market Trends 33
2.5 Porters Fiver Forces Analysis 37
3 Segmentation of North America Market by Test 41
3.1 Market Overview by Test 41
3.2 Lipid Panel 43
3.3 Infectious Disease Testing 44
3.4 Liver Panel 45
3.5 Complete Blood Count (CBC) 46
3.6 Electrolyte Testing 47
3.7 Renal Panel 48
3.8 Other Tests 49
4 Segmentation of North America Market by Product 50
4.1 Market Overview by Product 50
4.2 Instruments 52
4.3 Assay Kits & Reagents 53
4.4 Software & Services 54
5 Segmentation of North America Market by Indication 55
5.1 Market Overview by Indication 55
5.2 Cardiovascular 57
5.3 Cancer 58
5.4 Infectious Disease 59
5.5 Stroke 60
5.6 Chronic Lower Respiratory Diseases 61
5.7 Diabetes 62
5.8 Other Indications 63
6 Segmentation of North America Market by Patient Gender 64
6.1 Market Overview by Patient Gender 64
6.2 Male Patients 66
6.3 Female Patients 67
7 Segmentation of North America Market by Age Group 68
7.1 Market Overview by Age Group 68
7.2 Age 44 and below 70
7.3 Age 45-64 71
7.4 Age 65 and over 72
8 Segmentation of North America Market by End User 73
8.1 Market Overview by End User 73
8.2 Hospital & Clinics Laboratory 75
8.3 Diagnostic Laboratory 76
8.4 Point-of-Care Testing 77
8.5 Other End Users 78
9 North America Market 2021-2031 by Country 79
9.1 Overview of North America Market 79
9.2 U.S. 82
9.3 Canada 86
9.4 Mexico 88
10 Competitive Landscape 90
10.1 Overview of Key Vendors 90
10.2 New Product Launch, Partnership, Investment, and M&A 93
10.3 Company Profiles 94
Abbott Laboratories 94
Becton, Dickinson and Company 96
BioMerieux SA 97
Bio-Rad Laboratories Inc. 98
Bio-Reference Laboratories 99
Bioscientia Healthcare 100
Charles River Laboratories 101
Danaher Corporation 102
Hoffmann-La Roche AG 103
Hologic Inc. 104
Qiagen NV 105
Siemens Healthcare 106
Thermo Fisher Scientific 107
RELATED REPORTS 108